Familial defective apolipoprotein B-100: Detection and haplotype analysis of the Arg3500→Gln mutation in hyperlipidemic Chinese

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 385-390

  Teng, Yen Ni ^a   Pan, Ju Pin ^b   Chou, Shiu Ching ^b   Tai, Der Yan ^c   Lee Chen, Guey Jen ^a  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c Wei Gong Memorial Hospital   (Taiwan)

Author keywords

Familial defective apolipoprotein B 100; Haplotype; R3500Q mutation

Indexed keywords

APOLIPOPROTEIN B100;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CODON; FAMILIAL HYPERLIPEMIA; FEMALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AMINO ACID SUBSTITUTION; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GENE FREQUENCY; HAPLOTYPES; HETEROZYGOTE; HUMANS; HYPERLIPIDEMIAS; INFANT; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0033811075     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00481-5     Document Type: Article

References (32)

1. Innerarity T.L., Mahley R.W., Weisgraber K.H., Bersot T.P., Krauss R.M., Vega G.L., Grundy S.M., Friedl W., Davignon J., McCarthy B.J. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J. Lipid Res. 31:1990;1337-1349.
2. Tybjærg-Hansen A., Humphries S.E. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolaemia and premature coronary artery disease. Atherosclerosis. 96:1992;91-107.
3. Soria L.F., Ludwig E.H., Clarke H.R.G., Vega G.L., Grundy S.M., McCarthy B.J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 86:1989;587-591.
4. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
5. Innerarity T.L., Weisgraber K.H., Arnold K.S., Mahley R.W., Krauss R.M., Vega G.L., Grundy S.M. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84:1987;6919-6923.
6. Gaffney D., Reid J.M., Cameron I.M., Vass K., Caslake M.J., Shepherd J., Packard C.J. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;1025-1029.
7. Pullinger C.R., Hennessy L.K., Chatterton J.E., Liu W., Love J.A., Mendel C.M., Frost P.H., Malloy M.J., Schumaker V.N., Kane J.P. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 95:1995;1225-1234.
8. Tybjærg-Hansen A., Steffensen R., Meinertz H., Schnohr P., Nordestgaard B.G. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. New Engl. J. Med. 338:1998;1577-1584.
9. Ludwig E.H., McCarthy B.J. Haplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am. J. Hum. Genet. 47:1990;712-720.
10. Rauh G., Schuster H., Fischer J., Keller C., Wolfram G., Zöllner N. Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)→glutamine mutation. Atherosclerosis. 88:1991;219-226.
11. Leren T.P., Rødningen O.K., Tonstad S., Røsby O., Urdal P., Ose L. Identification of the apo B-3500 mutation in the Norwegian population. Scand. J. Clin. Lab. Invest. 55:1995;217-221.
12. Wenham P.R., Bloomfield P., Blundell G., Penney M.D., Rae P.W.H., Walker S.W. Familial defective apolipoprotein B-100: a study of patients from lipid clinics in Scotland and Wales. Ann. Clin. Biochem. 33:1996;443-450.
13. Rabes J.P., Varret M., Saint-Jore B., Erlich D., Jondeau G., Krempf M., Giraudet P., Junien C., Boileau C. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500→Gln and ARG3531→CYS mutations in a French population. Hum. Mutat. 10:1997;160-163.
14. 3500→glutamine associated with familial defective apolipoprotein B-100. J. Lipid Res. 34:1993;799-805.
15. Bersot T.P., Russell S.J., Thatcher S.R., Pomernacki N.K., Mahley R.W., Weisgraber K.H., Innerarity T.L., Fox C.S. A unique haplotype of the apolipoprotein B-100 allele associated with familiar defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J. Lipid Res. 34:1993;1149-1154.
16. Abdel-Wareth L.O., Pimstone S.N., Lagarde J.P., Raisonnier A., Benlian P., Pritchard H., Hayden M.R., Frohlich J.J. Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: identification of a unique haplotype of the apolipoprotein B-100 allele. Atherosclerosis. 135:1997;181-185.
17. 3500→tryptophan mutation associated with a unique haplotype. Clin. Chem. 43:1997;916-923.
18. 3500→Trp mutation in hyperlipidemic Chinese. Clin. Chem. 44:1998;1659-1665.
19. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel, Arch Intern Med 1988;148:36-69.
20. Pan WH, Hung YT, Shaw NS, Huang CJ, Tseng MS, Chen SG. Ecological study on diet, lifestyle, and chronic disease mortality in Taiwan. Report to National Science Council, Executive Yuan, Republic of China, 1990.
21. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19:1973;476-482.
22. Allain C.C., Poon L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20:1974;470-475.
23. Ludwig E.H., Blackhart B.D., Pierotti V.C., Caiati L., Fortier C., Knott T., Scott J., Mahley R.W., Levy-Wilson B., McCarthy B.J. DNA sequence of the human apolipoprotein B gene. DNA. 6:1987;363-372.
24. Tybjærg-Hansen A., Gallagher J., Vincent J., Houlston R., Talmud P., Dunning A.M., Seed M., Hamsten A., Humphries S.E., Myant N.B. Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis. 80:1990;235-242.
25. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-termination inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
26. Hansen P.S., Rudiger N., Tybjærg-Hansen A., Faergeman O., Gregersen N. Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI. J. Lipid Res. 32:1991;1229-1233.
27. Ludwig E.H., Friedl W., McCarthy B.J. High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am. J. Hum. Genet. 45:1989;458-464.
28. Miserez A.R., Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolaemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;1719-1729.
29. Pimstone S.N., Sun X.M., du Souich C., Frohlich J.J., Hayden M.R., Soutar A.K. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler. Thromb. Vasc. Biol. 18:1998;309-315.
30. Dunning A.M., Renges H.H., Xu C.F., Peacock R., Brasseur R., Laxer G., Tikkanen M.J., Butler R., Saha N., Hamsten A., Rosseneu M., Talmud P., Humphries S.E. Two amino acid substitutions in apolipoprotein B are in complete allelic association with the antigen group (x/y) polymorphism: evidence for little recombination in the 3′ end of the human gene. Am. J. Hum. Genet. 50:1992;208-221.
31. Youssoufian H., Kazazian H.H., Phillips D.G., Aronis S., Tsiftis G., Brown V.A., Antonarakis S.E. Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature. 324:1986;380-382.
32. Cooper D.N., Youssoufian H. The CpG dinucleotide and human genetic disease (review). Hum. Genet. 78:1988;151-155.